Ocata Therapeutics, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocata Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ocata Therapeutics, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 8.49 | 76,666 | 650,894 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 8.49 | 35,334 | 299,986 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 6.20 | 12,858 | 79,720 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 15.70 | 150,000 | 2,355,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 19.50 | 17,834 | 347,763 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 9.80 | 53,500 | 524,300 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Option Exercise | D | 21.00 | 40,000 | 840,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Lanza Robert | Chief Scientific Of ... | Sell | U | 8.50 | 231,509 | 1,967,827 | 0 | 231.5 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO & CFO | Option Exercise | D | 8.49 | 112,000 | 950,880 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO & CFO | Option Exercise | D | 7.78 | 140,000 | 1,089,200 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Myles Edward H | COO & CFO | Sell | U | 8.50 | 56,000 | 476,000 | 0 | 56 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Option Exercise | D | 10.37 | 417 | 4,324 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | PERRY GREGORY D | Director | Sell | U | 8.50 | 21,417 | 182,045 | 0 | 21.4 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LEVY BRIAN | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LEVY BRIAN | Director | Sell | U | 8.50 | 12,500 | 106,250 | 0 | 12.5 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Jooste H Le Roux | SVP of Bus Developm ... | Option Exercise | D | 6.32 | 75,000 | 474,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Jooste H Le Roux | SVP of Bus Developm ... | Sell | U | 8.50 | 25,000 | 212,500 | 0 | 25 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 18.50 | 5,000 | 92,500 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Option Exercise | D | 13.50 | 500 | 6,750 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Sell | U | 8.50 | 15,530 | 132,005 | 0 | 15.5 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Sell | U | 8.50 | 15,530 | 132,005 | 0 | 15.5 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | SHAPIRO ALAN C | Director | Sell | U | 8.50 | 252,206 | 2,143,751 | 0 | 252.2 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Anglade Eddy | Chief Medical Offic ... | Option Exercise | D | 8.49 | 112,000 | 950,880 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Anglade Eddy | Chief Medical Offic ... | Option Exercise | D | 8.99 | 100,000 | 899,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Anglade Eddy | Chief Medical Offic ... | Sell | U | 8.50 | 56,000 | 476,000 | 0 | 56 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.39 | 10,000 | 63,900 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 7.94 | 100,000 | 794,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.17 | 10,000 | 61,700 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 6.00 | 1,250 | 7,500 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Option Exercise | D | 8.00 | 3,621 | 28,968 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Heffernan Michael Thomas | Director | Sell | U | 8.50 | 31,000 | 263,500 | 0 | 31 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Option Exercise | D | 9.00 | 834 | 7,506 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LOSHITZER ZOHAR | Director | Sell | U | 8.50 | 21,834 | 185,589 | 0 | 21.8 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 8.36 | 5,000 | 41,800 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.39 | 5,000 | 31,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 6.17 | 5,000 | 30,850 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 5.79 | 5,000 | 28,950 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 9.00 | 5,000 | 45,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 20.00 | 20,000 | 400,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Option Exercise | D | 14.30 | 1,250 | 17,875 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | LANGER ROBERT | Director | Sell | U | 8.50 | 51,000 | 433,500 | 0 | 51 K to 0 (-100.00 %) |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Option Exercise | D | 6.55 | 300,000 | 1,965,000 | 0 | |
| Feb 11 2016 | ACTC | Ocata Therapeutics ... | Wotton Paul K | President and CEO | Sell | U | 8.50 | 277,500 | 2,358,750 | 0 | 277.5 K to 0 (-100.00 %) |